References: Baker JF (2026): Diagnosis and differential diagnosis of rheumatoid arthritis
This triple mechanism distinguishes it structurally from existing licensed treatments such as semaglutide (GLP-1 only) or tirzepatide (GLP-1 and GIP)
This dose-cycle length relationship should be considered in protocol design to optimize the balance between effect and safety
emjreviews.com Pickart, L., Vasquez-Soltero, J
Tirzepatide is FDAapproved for specific indications, including type 2 diabetes and, at certain doses and brand names, chronic weight management in adults with defined BMI criteria plus at least one weight-related condition, when combined with lifestyle change
GSTM2 deletion strongly promotes hepatic fat accumulation To investigate the function of GSTM2 in the progression of hepatic steatosis, we generated a GSTM2 knockout ( GSTM2 KO) mouse (Supplementary Fig